Highlights
NASDAQ: AMGN       Amgen Inc
Last Price Today's Change   Day's Range   Trading Volume
219.67   -1.64 (0.74%)  218.54 - 221.69  2,255,194

Overview

 
Avg Volume (4 weeks):2,361,560
4 Weeks Range:200.783 - 225.26
4 Weeks Price Volatility (%):
77.16%
52 Weeks Range:166.30 - 225.26
52 Weeks Price Volatility (%):
90.52%
Average Price Target: 140.00
Price Target Upside/Downside: -79.67

Headlines



No recent Headlines for this stock.


Business Background

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.

  Be the first to like this.
 


 

2954  2614  494  2908 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.702+0.032 
 FCEL 0.827+0.282 
 AMD 37.52+0.81 
 ET 11.16-0.50 
 GE 11.29-0.13 
 AABA 19.630.00 
 DIS 148.72+10.14 
 BAC 32.79-0.30 
 F 8.81-0.23 
 UBER 26.71+0.01 
Partners & Brokers